The role of targeted MRI-ultrasound fusion biopsies of the prostate in patients suspected for prostate cancer

Completed

• Conditions: malignant neoplasm of the prostate; Prostate cancer; 10038364

• Registration Number: NL-OMON44626
• Lead Sponsor: Isala Klinieken

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 350

Inclusion Criteria

- Age>18 years,
- Indication for undergoing prostate biopsies
- Written informed consent

Exclusion Criteria

- Patients who are suspected in advance to have bone metastases
- Patient not able to undergo MRI

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>All found prostate cancers </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Classification of the found prostate cancers<br /><br><br /><br>The amount of patients eligible for Active Surveillance </p><br>